Equities

Sakar Healthcare Ltd

Sakar Healthcare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)325.20
  • Today's Change-3.00 / -0.91%
  • Shares traded18.04k
  • 1 Year change+1.31%
  • Beta0.7818
Data delayed at least 15 minutes, as of Sep 20 2024 11:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments4.663571
Total Receivables, Net209221142
Total Inventory281161145
Prepaid expenses8.444.602.23
Other current assets, total213138140
Total current assets716559500
Property, plant & equipment, net3,1312,7312,059
Goodwill, net------
Intangibles, net1500
Long term investments------
Note receivable - long term3.013.018.13
Other long term assets2170110
Total assets3,8873,3632,678
LIABILITIES
Accounts payable275261305
Accrued expenses------
Notes payable/short-term debt13913045
Current portion long-term debt/capital leases1057933
Other current liabilities, total727584
Total current liabilities591545468
Total long term debt550982850
Total debt7941,192929
Deferred income tax1008671
Minority interest------
Other liabilities, total231714
Total liabilities1,2631,6301,403
SHAREHOLDERS EQUITY
Common stock217190171
Additional paid-in capital1,560860546
Retained earnings (accumulated deficit)853689559
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(7.09)(6.02)(1.56)
Total equity2,6231,7331,275
Total liabilities & shareholders' equity3,8873,3632,678
Total common shares outstanding191917
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.